Danna International (Offer Nissim Presents)

Fourth Paradigm, a Leader in Enterprise AI, Listed on the Main Board of the Hong Kong Stock Exchange

Retrieved on:

Thursday, September 28, 2023

Dai, International, Education, Telecommunications, Danna International (Offer Nissim Presents), Stock exchange, Motherboard, Trust, Acquisition, The Fourth Paradigm, Growth, AI, Transport, Hong Kong Stock Exchange, HK, Sales, HKEX

HONG KONG, Sept 28, 2023 - (ACN Newswire) - China's largest platform-centric decision-making AI company[1] - Beijing Fourth Paradigm Technology Co., Ltd. (stock code: 6682.HK), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange").

Key Points:

HONG KONG, Sept 28, 2023 - (ACN Newswire) - China's largest platform-centric decision-making AI company[1] - Beijing Fourth Paradigm Technology Co., Ltd. (stock code: 6682.HK), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange").
(2) Use for expanding the Company's offerings, build its brand and enter into new industry sectors over the next three years.
The Fourth Paradigm's Hong Kong Offering was over-subscribed by approximately 11.4 times of the 1,839,600 shares offered.
Founded in 2014, Beijing Fourth Paradigm Technology Co., Ltd. is a leader in enterprise AI.

A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK

Retrieved on:

Monday, September 25, 2023

HONG KONG, Sept 25, 2023 - (ACN Newswire) - Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today.

Key Points:

HONG KONG, Sept 25, 2023 - (ACN Newswire) - Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today.
As a biotechnology company dedicated to developing BsAb-based therapies, YZY Biopharma's core business model is to in-house discover, develop and commercialize BsAb-based therapies to treat cancer-associated complications, cancer and age-related ophthalmologic diseases.
The Company has received supports from CSPC Pharmaceutical Group Limited ("CSPC"), a well-known pharmaceutical company in China in 2018.
Dr. Zhou Pengfei, the co-founder, chairman, executive director and CEO of YZY Biopharma said, "Today marked a milestone in YZY Biopharma's development.

YSB Inc. Global Offering

Retrieved on:

Thursday, June 15, 2023

HONG KONG, June 15, 2023 - (ACN Newswire) - YSB Inc. (the "Company"; Stock code: 9885) announced the details of its global offering (the "Global Offering") and its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange").

Key Points:

HONG KONG, June 15, 2023 - (ACN Newswire) - YSB Inc. (the "Company"; Stock code: 9885) announced the details of its global offering (the "Global Offering") and its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange").
Highlights of the Global Offering:
-- Number of Offer Shares under the Global Offering: 15,808,800 Shares (subject to the Over-allotment Option).
Assuming that the Over-allotment Option is not exercised, after deducting the underwriting commissions and other estimated offering expenses payable by us in connection with the Global Offering, and assuming an Offer Price of HK$21.00 per Share (being the mid-point of the Offer Price), the Company estimates that it will receive gross proceeds of approximately HK$332.0 million from the Global Offering, and net proceeds of approximately HK$253.6 million from the Global Offering.
The Cornerstone Placing will form part of the International Offering, and Cornerstone Investor will not acquire any Offer Shares under the Global Offering (other than pursuant to the Cornerstone Investment Agreement).

Logory (Stock code: 2482) Announces its Global Offering

Retrieved on:

Monday, February 27, 2023

In 2002, the predecessor of Logory was established in Beijing.

Key Points:

In 2002, the predecessor of Logory was established in Beijing.
The Company has successfully built a digitalized ecosystem for road freight transportation in China.
The Company provides digital freight services and solutions to shippers, such as logistics companies and cargo owners, as well as truckers.
Haitong International Securities Company Limited is the Overall Coordinator, Sole Global Coordinator, Joint Bookrunner and Joint Lead Manager.

BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

Retrieved on:

Friday, January 13, 2023

Trust, Language isolate, International, Motherboard, Marketing, History, Growth, Danna International (Offer Nissim Presents), Teleport Communications Group, Neology, Hong Kong Stock Exchange, Stock exchange, CCASS, Property management

The Offer Price is HK$19.32 per share.

Key Points:

The Offer Price is HK$19.32 per share.
The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been very significantly oversubscribed.
The Offer Shares initially offered under the International Offering have been moderately oversubscribed, representing approximately 4.7 times of the total number of 36,482,500 International Offer Shares initially available for subscription under the International Offering.
The outstanding share oversubscription shows the trust and support of global investors for the Company's business development and lays a firm ground for the Company's long-term growth.

SinoHytec Successfully Listed on the Main Board of HKEX

Retrieved on:

Thursday, January 12, 2023

R, Trust, HKEX, International, Motherboard, Today, S. D. Warren Co. v. Maine Board of Environmental Protection, Danna International (Offer Nissim Presents), Research, Hong Kong Stock Exchange, Stock exchange, Renewable energy

SinoHytec adheres to the R&D principles of "Advance Research", "Continuous Development" and "In-depth Promotion".

Key Points:

SinoHytec adheres to the R&D principles of "Advance Research", "Continuous Development" and "In-depth Promotion".
In addition, the Company plans to develop and manufacture membrane electrodes, another major fuel cell stack component, through its main associate company, Shanghai Maximfuelcell Technology Co., Ltd.
Mr. Zhang Guoqiang, Chairman, Executive Director and General Manager of SinoHytec said: "Today, SinoHytec is officially listed on the Main Board of the Hong Kong Stock Exchange, which is an important milestone in the Company's development and marks the entry of SinoHytec into the international capital market.
We would like to express our gratitude to our investors for their trust and support of SinoHytec.

SinoHytec Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange, Offer Price Between HK$60 and HK$76 per H Share, Raise up to HK$1,540.7 million

Retrieved on:

Thursday, December 29, 2022

The Hong Kong Public Offering will commence at 9 a.m., December 29, 2022 (Thursday), and close at 12:00 noon on January 5, 2023 (Thursday).

Key Points:

The Hong Kong Public Offering will commence at 9 a.m., December 29, 2022 (Thursday), and close at 12:00 noon on January 5, 2023 (Thursday).
Dealings in the shares of SinoHytec on the Main Board of the Hong Kong Stock Exchange is expected to commence on January 12, 2023 (Thursday), with the stock code 2402 and in board lots of 50 Offer Shares each.
Established in 2012, the company is a pioneer in the R&D and commercialization of fuel cell systems in China and started batch production in 2016.
As of December 20, 2022, the company's fuel cell systems have powered over 2,800 fuel cell vehicles on the road in China.

Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX

Retrieved on:

Tuesday, December 13, 2022

HONG KONG, Dec 13, 2022 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").

Key Points:

HONG KONG, Dec 13, 2022 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").
In 2021, its global sales volume of PCI balloon products reached approximately 866,000 units
-- A major PTA balloon developer and manufacturer in the global PTA balloons market, ranked No.
Dealing of the shares is expected to commence on the Main Board of HKEX on 23 December 2022 (Friday) under the stock code 6929.
OrbusNeich, headquartered in Hong Kong Science Park, is a major global medical device manufacturer specialized in interventional instruments for PCI and PTA procedures.

360 DigiTech Announces Pricing of Global Offering

Retrieved on:

Wednesday, November 23, 2022

SHANGHAI, China, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 360 DigiTech, Inc. (NASDAQ: QFIN) (360 DigiTech or the Company), a Credit-Tech platform in China, today announced the pricing of its global offering (the Global Offering) of 5,540,000 Class A ordinary shares of the Company (the Offer Shares).

Key Points:

SHANGHAI, China, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 360 DigiTech, Inc. (NASDAQ: QFIN) (360 DigiTech or the Company), a Credit-Tech platform in China, today announced the pricing of its global offering (the Global Offering) of 5,540,000 Class A ordinary shares of the Company (the Offer Shares).
The Global Offering comprises a Hong Kong public offering (the Hong Kong Public Offering) and an international offering (the International Offering).
Citigroup Global Markets Asia Limited and China International Capital Corporation Hong Kong Securities Limited act as the joint global coordinators for the proposed Global Offering.
Citigroup Global Markets Asia Limited (in relation to the Hong Kong Public Offering only), Citigroup Global Markets Limited (in relation to the International Offering only) and China International Capital Corporation Hong Kong Securities Limited, CCB International Capital Limited, Futu Securities International (Hong Kong) Limited, and Tiger Brokers (HK) Global Limited are the joint bookrunners for the proposed Global Offering.

360 DigiTech Launches Global Offering

Retrieved on:

Friday, November 18, 2022

SHANGHAI, China, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 360 DigiTech, Inc. (NASDAQ: QFIN) (360 DigiTech or the Company), a leading Credit-Tech platform in China, today announced the launch of its global offering (the Global Offering) of 5,540,000 Class A ordinary shares of the Company, which comprises a Hong Kong public offering of initially 560,000 Class A ordinary shares commencing today (the Hong Kong Public Offering) and an international offering of initially 4,980,000 Class A ordinary shares commencing today (the International Offering), and listing of the Companys Class A ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the Hong Kong Stock Exchange) under the stock code 3660.

Key Points:

SHANGHAI, China, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 360 DigiTech, Inc. (NASDAQ: QFIN) (360 DigiTech or the Company), a leading Credit-Tech platform in China, today announced the launch of its global offering (the Global Offering) of 5,540,000 Class A ordinary shares of the Company, which comprises a Hong Kong public offering of initially 560,000 Class A ordinary shares commencing today (the Hong Kong Public Offering) and an international offering of initially 4,980,000 Class A ordinary shares commencing today (the International Offering), and listing of the Companys Class A ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the Hong Kong Stock Exchange) under the stock code 3660.
Citigroup Global Markets Asia Limited (in relation to the Hong Kong Public Offering only), Citigroup Global Markets Limited (in relation to the International Offering only) and China International Capital Corporation Hong Kong Securities Limited, CCB International Capital Limited, Futu Securities International (Hong Kong) Limited, and Tiger Brokers (HK) Global Limited are the joint bookrunners for the proposed Global Offering.
Citigroup Global Markets Asia Limited (in relation to the Hong Kong Public Offering only), Citigroup Global Markets Limited (in relation to the International Offering only) and China International Capital Corporation Hong Kong Securities Limited, CCB International Capital Limited, Futu Securities International (Hong Kong) Limited, Tiger Brokers (HK) Global Limited, and Livermore Holdings Limited are the joint lead managers for the proposed Global Offering.
The proposed Global Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Global Offering may be completed, or as to the actual size or terms of the Global Offering.